Lung Ultrasound for Cardiologists in the Time of COVID-19.


Journal

The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280

Informations de publication

Date de publication:
07 2020
Historique:
received: 16 04 2020
revised: 08 05 2020
accepted: 08 05 2020
pubmed: 18 5 2020
medline: 4 8 2020
entrez: 17 5 2020
Statut: ppublish

Résumé

Lung ultrasound (LUS) is a point-of-care ultrasound technique used for its portability, widespread availability, and ability to provide real-time diagnostic information and procedural guidance. LUS outperforms lung auscultation and chest X-ray, and it is an alternative to chest computed tomography in selected cases. Cardiologists may enhance their physical and echocardiographic examination with the addition of LUS. We present a practical guide to LUS, including device selection, scanning, findings, and interpretation. We outline a 3-point scanning protocol using 2-dimensional and M-mode imaging to evaluate the pleural line, pleural space, and parenchyma. We describe LUS findings and interpretation for common causes of respiratory failure. We provide guidance specific of COVID-19, which at the time of writing is a global pandemic. In this context, LUS emerges as a particularly useful tool for the diagnosis and management of patients with cardiopulmonary disease.

Identifiants

pubmed: 32416318
pii: S0828-282X(20)30453-0
doi: 10.1016/j.cjca.2020.05.008
pmc: PMC7235628
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1144-1147

Informations de copyright

Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Références

Intensive Care Med. 2012 Apr;38(4):577-91
pubmed: 22392031
JACC Cardiovasc Imaging. 2018 Nov;11(11):1692-1705
pubmed: 30409330
J Am Soc Echocardiogr. 2020 Jun;33(6):670-673
pubmed: 32503704

Auteurs

Omid Kiamanesh (O)

Echocardiography Program, Division of Cardiology, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada; Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada. Electronic address: omid.kiamanesh@ucalgary.ca.

Lea Harper (L)

Division of Respirology, University of Toronto, Toronto, Ontario, Canada; Division of Respirology, University of Calgary, Calgary, Alberta, Canada.

Katie Wiskar (K)

Division of General Internal Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Warren Luksun (W)

Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada; Department of Anaesthesia, University of Toronto, Toronto, Ontario, Canada; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.

Michael McDonald (M)

Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.

Heather Ross (H)

Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.

Anna Woo (A)

Echocardiography Program, Division of Cardiology, Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.

John Granton (J)

Division of Respirology, University of Toronto, Toronto, Ontario, Canada; Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH